Pharmacokinetic and Safety Study of HYR-PB21 vs Bupivacaine Hydrochloric Acid in Healthy Participants

NCT07717086 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Analgesia

Interventions

DRUG: HYR-PB21， 100 mg
DRUG: HYR-PB21， 200 mg
DRUG: HYR-PB21， 400 mg
DRUG: Bupivacaine hydrochloride， 100 mg (as base)

Sponsor

Fruithy Holdings Limited

Collaborators

[object Object]